Disease Areas

The disorders we are targeting – schizophrenia and Parkinson’s disease – exert a profound human impact across the globe today. We share the belief of many physicians that the treatment benefits for these disorders have remained virtually unimproved and unsatisfactory for too long.

Our clinical development programs are shaped by our insights into the etiology and manifestation of these diseases, and we are focused clearly on the unmet needs of the substantial patient populations whose lives they define.